Water Island Capital’s Cidara Therapeutics CDTX Stock Holding History

Water Island Capital’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-76,900	Closed	-$17M	–	104
2025 Q4	$17M	Buy	+76,900	New	+$12.4M	1.83%	21

Water Island Capital's CDTX Position: Q1 2026 in Review

Water Island Capital sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 150,708 shares — an estimated $33.3M sold.

Water Island Capital first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $33.3M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Water Island Capital reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Water Island Capital sold 150,708 Cidara Therapeutics shares in Q1 2026, an estimated $33.3M.
Water Island Capital first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Water Island Capital's Cidara Therapeutics position peaked at $33.3M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Water Island Capital's 13F filing for Q1 2026, filed 15 May 2026.